Sign in
Active, not recruitingNo phase

Comparison of NEWS2 and Machine Learning for Early Sepsis Warning

Key facts

Who runs it
Kocaeli Derince Education and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
100 people, planned
Started
22 Jul 2026
Ended
13 Aug 2026
Type of study
Observational
Treatments tested
  • Observational Study - No Intervention
Record updated
13 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patients aged 18 years and older
  • Admitted to Kocaeli City Hospital Anesthesiology and Reanimation Clinic
  • Suspected infection at the time of hospital admission
  • Complete vital signs recorded
  • Informed consent obtained from the patient or legal representative

Who cannot take part

  • Patients with chronic kidney disease requiring dialysis
  • Patients with a history of organ transplantation
  • Patients under 18 years of age
  • Pregnant patients
  • Patients with incomplete data

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective observational study aims to objectively measure the lead-time (the time from the first KDS alert to sepsis diagnosis) of the NEWS2-based clinical decision support system (KDS) and compare its early warning performance with a machine learning model trained on 2000 patients and externally validated. The study seeks to answer the following main questions:

Read full original descriptionShow less

How early does the NEWS2-based KDS provide an alert before sepsis diagnosis?

Does a machine learning model, developed using logistic regression and externally validated in a prospective cohort, offer superior specificity and comparable sensitivity to KDS?

Participants who are already receiving routine clinical care at Kocaeli City Hospital will have their vital signs and laboratory data monitored as part of standard practice. NEWS2 scores will be calculated automatically and the time of the first alert (T0) will be recorded. Sepsis diagnosis will be confirmed by an increase in SOFA score ≥ 2 (T1), evaluated by two independent and blinded physicians. Lead-time will be calculated as the difference between T1 (hours×60) and T0 (minutes). The machine learning model will be tested prospectively on this cohort, and its performance will be compared with KDS using sensitivity, specificity, F1 score, ROC-AUC, and accuracy.

Treatments tested

  • Observational Study - No Intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of NEWS2 and a Machine Learning Model for Early Sepsis Warning: A Prospective Observational Study
Record updated
13 August 2026